Key regions: United States, Europe, Brazil, Japan, United Kingdom
The demand for Bronchodilator Drugs in Mozambique has been on the rise in recent years due to various factors.
Customer preferences: Bronchodilator Drugs are primarily used to treat respiratory illnesses such as asthma and chronic obstructive pulmonary disease (COPD). The increasing prevalence of these diseases in Mozambique has led to a rise in demand for bronchodilator drugs. Additionally, the affordability and accessibility of these drugs have also contributed to their increasing popularity.
Trends in the market: One of the major trends in the Bronchodilator Drugs market in Mozambique is the increasing preference for combination therapies. Combination therapies involve the use of two or more drugs to treat respiratory illnesses. This trend is primarily driven by the need to improve treatment outcomes and reduce the frequency of exacerbations. Another trend in the market is the increasing popularity of long-acting bronchodilators. Long-acting bronchodilators provide sustained relief from symptoms and are preferred by patients who require long-term treatment.
Local special circumstances: Mozambique is a low-income country with a high burden of communicable diseases such as HIV/AIDS, tuberculosis, and malaria. This has led to a strain on the healthcare system, and resources are often directed towards the treatment of these diseases. However, the increasing prevalence of respiratory illnesses has led to a shift in focus towards the treatment of these diseases as well. Additionally, the lack of awareness and education about respiratory illnesses has led to a delay in diagnosis and treatment, which has further contributed to the rising demand for bronchodilator drugs.
Underlying macroeconomic factors: Mozambique has a growing economy, with a focus on natural resources such as coal and gas. The increasing economic growth has led to an increase in disposable income, which has contributed to the rising demand for healthcare services. Additionally, the government has implemented various policies to improve access to healthcare services, which has further contributed to the increasing demand for bronchodilator drugs. However, the healthcare system in Mozambique is still underdeveloped, and there is a lack of infrastructure and trained healthcare professionals. This has led to a reliance on international aid and organizations to provide healthcare services.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
